Musculoskeletal
Tibia Fracture
6
Pipeline Programs↗
2
Active Trials↗
6
Companies Involved↗
Tibia Fracture is an early-stage landscape with 6 programs across 6 companies. The most active players are Hyundai Pharmaceutical Co., LTD., EMD Serono, Kenvue Brands. 2 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 21
Phase 31
Analysis
Trial Status
8
clinical trials
Unknown status2 · 25%
Completed2 · 25%
Recruiting1 · 13%
Terminated1 · 13%
Withdrawn1 · 13%
Not yet recruiting1 · 13%
Clinical Trials
Trial Activity
8 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)